FRA
Front Row Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38K | Sell |
13
-8
| -38% | -$849 | ﹤0.01% | 490 |
|
|
2025
Q1 | $2.61K | Hold |
21
| – | – | ﹤0.01% | 438 |
|
|
2024
Q4 | $2.59K | Hold |
21
| – | – | ﹤0.01% | 436 |
|
|
2024
Q3 | $2.34K | Sell |
21
-51
| -71% | -$5.68K | ﹤0.01% | 440 |
|
|
2024
Q2 | $7.69K | Sell |
72
-9
| -11% | -$961 | ﹤0.01% | 641 |
|
|
2024
Q1 | $9.75K | Buy |
81
+60
| +286% | +$7.23K | ﹤0.01% | 595 |
|
|
2023
Q4 | $2.58K | Sell |
21
-50
| -70% | -$6.15K | ﹤0.01% | 405 |
|
|
2023
Q3 | $9.19K | Hold |
71
| – | – | ﹤0.01% | 540 |
|
|
2023
Q2 | $9K | Hold |
71
| – | – | ﹤0.01% | 545 |
|
|
2023
Q1 | $10K | Buy |
71
+27
| +61% | +$3.8K | ﹤0.01% | 531 |
|
|
2022
Q4 | $7K | Sell |
44
-4
| -8% | -$636 | ﹤0.01% | 566 |
|
|
2022
Q3 | $6K | Sell |
48
-10
| -17% | -$1.25K | ﹤0.01% | 614 |
|
|
2022
Q2 | $9K | Buy |
58
+6
| +12% | +$931 | ﹤0.01% | 534 |
|
|
2022
Q1 | $8K | Hold |
52
| – | – | ﹤0.01% | 596 |
|
|
2021
Q4 | $7K | Buy |
52
+12
| +30% | +$1.62K | ﹤0.01% | 667 |
|
|
2021
Q3 | $5K | Hold |
40
| – | – | ﹤0.01% | 738 |
|
|
2021
Q2 | $5K | Sell |
40
-1
| -2% | -$125 | ﹤0.01% | 741 |
|
|
2021
Q1 | $7K | Sell |
41
-1
| -2% | -$171 | ﹤0.01% | 638 |
|
|
2020
Q4 | $7K | Hold |
42
| – | – | ﹤0.01% | 613 |
|
|
2020
Q3 | $6K | Buy |
42
+3
| +8% | +$429 | ﹤0.01% | 641 |
|
|
2020
Q2 | $4K | Sell |
39
-1
| -3% | -$103 | ﹤0.01% | 694 |
|
|
2020
Q1 | $4K | Hold |
40
| – | – | ﹤0.01% | 666 |
|
|
2019
Q4 | $6K | Sell |
40
-2
| -5% | -$300 | ﹤0.01% | 575 |
|
|
2019
Q3 | $5K | Buy |
42
+10
| +31% | +$1.19K | ﹤0.01% | 597 |
|
|
2019
Q2 | $5K | Hold |
32
| – | – | ﹤0.01% | 580 |
|
|
2019
Q1 | $5K | Buy |
32
+14
| +78% | +$2.19K | ﹤0.01% | 586 |
|
|
2018
Q4 | $2K | Hold |
18
| – | – | ﹤0.01% | 792 |
|
|
2018
Q3 | $3 | Buy |
+18
| New | +$3 | ﹤0.01% | 694 |
|